Publications by authors named "Andrew D Goetz"

Claim this Profile
C
Crystal structure of (E)-2-[(2-bromopyridin-3-yl)methyl-idene]-6-meth-oxy-3,4-di-hydro-naphthalen-1(2H)-one and 3-[(E)-(6-meth-oxy-1-oxo-1,2,3,4-tetra-hydro-naphthalen-2-ylidene)meth-yl]pyridin-2(1H)-one.
Sarah K Zingales, Morgan E Moore, Andrew D Goetz, Clifford W Padgett

Acta Crystallogr E Crystallogr Commun· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
Alain C Mita, Louis J Denis, Eric K Rowinsky, Johann S Debono, Andrew D Goetz

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific igE serologic surveys.
David W Goetz, Bonnie A Whisman, Andrew D Goetz

Ann Allergy Asthma Immunol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.
Desirée Hao, Lisa A Hammond, S Gail Eckhardt, Amita Patnaik, Chris H Takimoto, Andrew D Goetz

Clin Cancer Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis